Non-muscle Invasive Bladder Cancer Clinical Trials in New Brunswick, New Jersey

3 studies are recruiting for non-muscle invasive bladder cancer in New Brunswick, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer

    This is a phase 2 open-label two cohort study of durvalumab plus monalizumab in patients with BCG-unresponsive or BCG-exposed CIS NMIBC. Arm A will enroll 43 participants who have cancer in situ (CIS) with or without high grade papillary urothelial cancer. Arm B will enroll 17 participants who do n…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
    Locations
    5 in total
    Run by
    John Sfakianos

    See if you can join NCT06503614 on ClinicalTrials.gov

  2. Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy

    Blue light cystoscopy (BLC) is a diagnostic procedure in bladder cancer where the inside of the bladder is observed with a camera to detect bladder lesions. Unlike regular white light cystoscopy, blue light cystoscopy makes use of a drug that induces fluorescence under blue light preferentially in …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Rutgers Cancer Institute, New Brunswick, New Jersey
    Locations
    8 in total
    Run by
    Photocure

    See if you can join NCT07144319 on ClinicalTrials.gov

  3. LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

    This study will evaluate the safety and efficacy of intravesical administration of detalimogene (EG-70) in the bladder and its effect on bladder tumors in patients with NMIBC. This study study consists of two phases; a Phase 1 dose-escalation to establish safety and recommended the phase 2 dose, fo…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
    Locations
    102 in total
    Run by
    enGene, Inc.

    See if you can join NCT04752722 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.